Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M602178200 on November 10, 2006

J. Biol. Chem., Vol. 282, Issue 2, 908-915, January 12, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/2/908    most recent
M602178200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karakiulakis, G.
Right arrow Articles by Roth, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karakiulakis, G.
Right arrow Articles by Roth, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cell Type-specific Effect of Hypoxia and Platelet-derived Growth Factor-BB on Extracellular Matrix Turnover and Its Consequences for Lung Remodeling*

George Karakiulakis{ddagger}, Eleni Papakonstantinou{ddagger}, Alexios J. Aletras§, Michael Tamm, and Michael Roth||1

From the {ddagger}Department of Pharmacology, School of Medicine, Aristotle University, GR-54124 Thessaloniki, Greece, §Laboratory of Biochemistry, Department of Chemistry, University of Patras, GR-26110 Patras, Greece, Pulmonary Cell Research and Pneumology, University Hospital Basel, CH-4031 Basel, Switzerland, and ||The Woolcock Institute for Medical Research, Sydney NSW-2050, Australia

Hypoxia is associated with extracellular matrix remodeling in several inflammatory lung diseases, such as fibrosis, chronic obstructive pulmonary disease, and asthma. In a human cell culture model, we assessed whether extracellular matrix modification by hypoxia and platelet-derived growth factor (PDGF) involves the action of matrix metalloproteinases (MMPs) and thereby affects cell proliferation. Expression of MMP and its activity were assessed by zymography and enzyme-linked immunosorbent assay in human lung fibroblasts and pulmonary vascular smooth muscle cells (VSMCs), and synthesis of soluble collagen type I was assessed by enzyme-linked immunosorbent assay. In both cell types, hypoxia up-regulated the expression of MMP-1, -2, and -9 precursors without subsequent activation. MMP-13 was increased by hypoxia only in fibroblasts. PDGF-BB inhibited the synthesis and secretion of all hypoxia-dependent MMP via Erk1/2 mitogen-activated protein (MAP) kinase activation. Hypoxia and PDGF-BB induced synthesis of soluble collagen type I via Erk1/2 and p38 MAP kinase. Hypoxia-induced cell proliferation was blocked by antibodies to PDGF-BB or by inhibition of Erk1/2 but not by the inhibition of MMP or p38 MAP kinase in fibroblasts. In VSMCs, hypoxia-induced proliferation involved Erk1/2 and p38 MAP kinases and was further increased by fibroblast-conditioned medium or soluble collagen type I via Erk1/2. In conclusion, hypoxia controls tissue remodeling and proliferation in a cell type-specific manner. Furthermore, fibroblasts may affect proliferation of VSMC indirectly by inducing the synthesis of soluble collagen type I.


Received for publication, March 8, 2006 , and in revised form, September 11, 2006.

* This work was supported by a grant from the Swiss National Fonds (SNF 32-061737). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 To whom correspondence should be addressed: Pulmonary Cell Research, Pneumology, University Hospital Basel, Petersgraben 4, CH-4031 Basel, Switzerland. Tel.: 41-61-2652391; Fax: 41-61-2652350; E-mail: Michaelr{at}med.usyd.edu.au.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
ChestHome page
E. J. Lee, K. H. In, J. H. Kim, S. Y. Lee, C. Shin, J. J. Shim, K. H. Kang, S. H. Yoo, C. H. Kim, H.-K. Kim, et al.
Proteomic Analysis in Lung Tissue of Smokers and COPD Patients
Chest, February 1, 2009; 135(2): 344 - 352.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
W. J. French, E. E. Creemers, and M. D. Tallquist
Platelet-Derived Growth Factor Receptors Direct Vascular Development Independent of Vascular Smooth Muscle Cell Function
Mol. Cell. Biol., September 15, 2008; 28(18): 5646 - 5657.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Belmadani, M. Zerfaoui, H. A. Boulares, D. I. Palen, and K. Matrougui
Microvessel vascular smooth muscle cells contribute to collagen type I deposition through ERK1/2 MAP kinase, {alpha}v{beta}3-integrin, and TGF-{beta}1 in response to ANG II and high glucose
Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H69 - H76.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement